The inhibition of the H3K79 methyltransferase DOT1L via EPZ004777 not only decreases enrichment of H3K79me2, but also attenuates the expression of FOXM1, which partially decelerates tumor growth by enhancing function of bone marrow-derived DCs 192. This evidence concerns the gene FOXM1 and neoplasm.